CPA6, FMO2, LGI1, SIAT1 and TNC are differentially expressed in early- and late-stage oral squamous cell carcinoma

CPA6, FMO2, LGI1, SIAT1 and TNC are differentially expressed in early- and late-stage oral squamous cell carcinoma – A pilot study

Published:2008-10 Issue:10 Volume:44 Page:941-948
ISSN:1368-8375
Container-title:Oral Oncology
language:en
Short-container-title:Oral Oncology

Author:

Fialka Florian,Gruber Rudolf Matthias,Hitt Reiner,Opitz Lennart,Brunner Edgar,Schliephake Henning,Kramer Franz-Josef

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Oral Surgery

Reference53 articles.

1. Cancer statistics, 2004;Jemal;CA Cancer J Clin,2004

2. Estimates of the worldwide incidence of 25 major cancers in 1990;Parkin;Int J Cancer,1999

3. The prognostic impact of metastatic pattern of lymph nodes in patients with oral and oropharyngeal squamous cell carcinomas;Wenzel;Eur Arch Otorhinolaryngol,2004

4. The role of novel oncogenes squamous cell carcinoma-related oncogene and phosphatidylinositol 3-kinase p110α in squamous cell carcinoma of the oral tongue;Estilo;Clin Cancer Res,2003

5. Overexpression of stathmin in oral squamous-cell carcinoma: correlation with tumour progression and poor prognosis;Kouzu;Bri J Cancer,2006

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Spontaneously hypertensive rats exhibit increased liver flavin monooxygenase expression and elevated plasma TMAO levels compared to normotensive and Ang II-dependent hypertensive rats;Frontiers in Physiology;2024-04-12

2. Discovery and identification of the prognostic significance and potential mechanism of FMO2 in breast cancer;Aging;2023-11-13

3. FMO family may serve as novel marker and potential therapeutic target for the peritoneal metastasis in gastric cancer;Frontiers in Oncology;2023-05-18

4. CBDCEM: An effective centrality based differential co-expression method for critical gene finding;Gene Reports;2022-12

5. Cancer-associated fibroblasts-derived FMO2 as a biomarker of macrophage infiltration and prognosis in epithelial ovarian cancer;Gynecologic Oncology;2022-11